MRCOG Part 2 – Knowledge Area 5 – Antenatal Care 

RCOG Green Top Guidelines

• Amniocentesis and Chorionic Villus Sampling – GTG No. 8 – October 2021
• Antepartum Haemorrhage – GTG No. 63 – November 2011
• Blood Transfusion in Obstetrics – GTG No. 47 May 2015
• Care of Women with Obesity in Pregnancy – GTG No. 72 – November 2018
• Care of Women Presenting with Suspected Preterm Prelabour Rupture of Membranes from 24+0 Weeks of Gestation – GTG No. 73 – June 2019
• Cervical Cerclage – GTG No. 75 – June 2022
• Chicken Pox in Pregnancy – GTG No. 13 – Updated 2024
• External Cephalic Version and Reducing the Incidence of Term Breech Presentation – GTG No. 20a – March 2017
• Female Genital Mutilation and its Management – GTG No. 53 – July 2015
• Identification and management of maternal sepsis during and following pregnancy – GTG No. 64 – December 2024
• Intrahepatic cholestasis of pregnancy – GTG No. 43 – August 2022
• Joint British Association for Sexual Health and HIV and Royal College of Obstetricians and Gynaecologists national UK guideline for the management of herpes simplex virus (HSV) in pregnancy and the neonate – August 2024
• Management of Breech Presentation – GTG No. 20b – March 2017
• Management of Monochorionic Twin Pregnancy – GTG No. 51 – November 2016
• Intrahepatic cholestasis of pregnancy – GTG No. 43 – June 2022
• Placenta Praevia and Placenta Accreta Spectrum: Diagnosis and Management – GTG No. 27a – June 2026
• Pregnancy and Breast Cancer – GTG No. 12 – March 2011
• Birth After Previous Caesarean Section – GTG No. 45 – October 2015
• Reduced Fetal Movements – GTG No. 57 – February 2026
• Reducing the Risk of Venous Thromboembolism during Pregnancy and the Puerperium – GTG No 37a – April 2015
• Small-for-Gestational-Age Fetus and a Growth Restricted Fetus, Investigation and Care – GTG No. 31 – May 2024
• Thromboembolic Disease in Pregnancy and the Puerperium- Acute Management – GTG No 37b – April 2015
• Vasa Praevia: Diagnosis and Management – GTG No. 27b – September 2018

NICE Guidelines

• Antenatal care for uncomplicated pregnancies – NICE NG201 – August 2021
• Antenatal and postnatal mental health- clinical management and service guidance – NICE CG192 – Updated February 2020
• Hypertension in pregnancy- diagnosis and management – NICE NG133 – Updated April 2023
• Preterm labour and birth – NICE NG25 – Updated June 2022
• Twin and triplet pregnancy – NICE NG137 – Updated April 2024

RCOG – Other Publications

• Air Travel and Pregnancy – RCOG Scientific Impact Paper No. 1 – May 2013
• Amniocentesis for Prenatal Diagnosis – RCOG Consent Advice No. 6a – January 2026
• Antenatal and Postnatal Analgesia – RCOG Scientific Impact Paper No. 59 – December 2018
• Care of Women with Preterm Prelabour Rupture of the Membranes Prior to 24+0 Weeks of Gestation – RCOG Scientific Impact Paper No. 76 – June 2025
• Chemical Exposures During Pregnancy- Dealing with Potential, but Unproven, Risks to Child Health – RCOG Scientific Impact Paper No. 37 – May 2013
• Chorionic Villous Sampling – RCOG Consent Advice 6b – January 2026
• Congenital Cytomegalovirus Infection – Update on Screening, Diagnosis and Treatment – RCOG Scientific Impact Paper No. 56 – September 2024
• Non-invasive Prenatal Testing for Chromosomal Abnormality using Maternal Plasma DNA – RCOG Scientific Impact Paper No. 15 – March 2014
• Registration of Stillbirth and Certification for Pregnancy Loss before 24 weeks of gestation – RCOG Good Practice No. 4 – January 2005
• Evidence to Support the Clinical Utility of Prenatal Exome Sequencing in the Evaluation of the Fetus with Congenital Anomalies – RCOG Scientific Impact Paper No. 64 – February 2021
• Prenatal Management of Pregnancies at Risk of Fetal Neonatal Alloimmune Thrombocytopenia (FNAIT) – RCOG Scientific Impact Paper No. 61 – April 2019
• The Combined Use of Ultrasound and Fetal Magnetic Resonance Imaging for a Comprehensive Fetal Neurological Assessment in Fetal Congenital Cardiac Defects – RCOG Scientific Impact Paper No. 60 – May 2019
• Managing Events Surrounding a Maternal Death and Supporting the Family and Staff – RCOG Good Practice Paper No 18 – February 2024
• Maternity Triage – RCOG Good Practice Paper No. 17 – December 2023
• Zika Virus Infection and Pregnancy – RCOG / RCM / PHE / HPS Clinical Guidealine – February 2019
• The Use of Novel Therapies in the Management of Haemolytic Disease of the Fetus and Newborn (HDFN) (Scientific Impact Paper No. 75) – 2025

Miscellaneous

• British Society of Haematology Guideline for the investigation and management of red cell antibodies in pregnancy – February 2025

TOG Articles

• Domestic violence – a neglected epidemic in obstetrics and gynaecology training –  TOG 2017;19:199–203
• Spontaneous preterm birth prevention in multiple pregnancy – TOG 2018 20:57-63
• Surgical causes of acute abdominal pain in pregnancy – TOG 2019 21:27-35
• Maternal, fetal, and neonatal outcomes associated with long-term use of corticosteroids during pregnancy – TOG 2019;21:117-125
• Smoking in pregnancy: pathophysiology of harm and current evidence for monitoring and cessation – TOG 2019;21:169-175
• Imaging in pregnancy- TOG 2019;21:255-262
• Fetal surgery for open spina bifida- TOG 2019;21:271-282
• Antenatal management of singleton pregnancies conceived using assisted reproductive technology – TOG 2020;22:34-44
• Syphilis in pregnancy: identifying and managing a historic problem on the rise – TOG 2020;22:209-216
• Multifetal pregnancy reduction and selective termination – TOG 2020;22:284-292
• Pre-implantation genetic testing for aneuploidy: the past, present and future – TOG 2020;22:293-304
• Care in pregnancies subsequent to stillbirth or perinatal death – TOG 2021;23:48-59
• Very advanced maternal age – TOG 2021;23:38-47
• Identification and management of fetal anaemia: a practical guide – TOG 2021;23:196-205
• The role of antenatal corticosteroids in improving neonatal outcomes – TOG 2021;23:246-257
• Pregnancy in underweight women: implications, management and outcomes – TOG 2022;24:50-57
• Opioid misuse in pregnancy – TOG 2022;24:101-108
• The diagnosis and management of fetal cardiac arrhythmias – TOG 2022;24:119-130
• Advanced abdominal pregnancy: challenges, update and review of current management – TOG 2022;24:195-204
• Obstetric and perinatal outcomes in women with endometriosis – TOG 2022:24 242-250
• Pitfalls of prenatal diagnosis associated with mosaicism – TOG 2023;25:28-37
• Non-immune hydrops fetalis: a practical guide for obstetricians – TOG 2023:25:110-120
• Prenatal genomic testing for ultrasound-detected fetal structural anomalies – TOG 2023:25: 121-130
• Gastrointestinal congenital anomalies requiring surgery: diagnosis, counselling, and management – TOG 2023;25:186-195
• Information sharing and communication in management of large for gestational age babies in non-diabetic mothers – TOG 2023;25: 282-290
• Preventing and reducing the morbidity and mortality of preterm birth in singleton pregnancies – TOG 2025;27:104-114
• Placenta accreta spectrum: imaging and diagnosis – TOG 2025;27:15-28
• Perinatal mental health: an overview of pathology, services and the law – TOG 2025;27:57-67
• Non-trophoblastic tumours of the placenta: pathophysiology, diagnosis and management – TOG 2025;27:91-103
• COVID-19 in pregnancy – TOG 2025;27:43-56
• Applications for cell-free fetal DNA testing beyond common aneuploidy – TOG 2025;27:197-206
• Placenta accreta spectrum: management update – TOG 2025;27:286-298
• The management of chronic pain in pregnancy – TOG 2026:28 16-29
• Assessment of fetal growth in twin pregnancies: evidence-based practice – TOG 2026:28 30-49
• Management of isolated abnormal amniotic fluid volume in pregnancy – TOG 2026:28 41-50